EUVIMEDEUVIMED entdecken
Crossref

Targeting a cell-specific microRNA repressor of CXCR4 ameliorates atherosclerosis in mice

Ismail Cimen iD, Lucia Natarelli iD, Zahra Abedi Kichi, James M Henderson iD, Floriana M Farina iD, Eva Briem iD, Maria Aslani iD, Remco T A Megens iD, Yvonne Jansen, Elizabeth Mann-Fallenbuchel, Selin Gencer, Johan Duchêne iD und 7 weitere

Science Translational Medicine · 2023-11 · 15 (720)

DOI: 10.1126/scitranslmed.adf3357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, 2023-11. Verfasst von Ismail Cimen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-Universität München, 80336 Munich, Germany. Hauptthemen laut MEDLINE: MicroRNAs, Atherosclerosis, Plaque, Atherosclerotic. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The CXC chemokine receptor 4 (CXCR4) in endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) is crucial for vascular integrity. The atheroprotective functions of CXCR4 in vascular cells may be counteracted by atherogenic functions in other nonvascular cell types. Thus, strategies for cell-specifically augmenting CXCR4 function in vascular cells are crucial if this receptor is to be useful as a therapeutic target in treating atherosclerosis and other vascular disorders. Here, we identified miR-206-3p as a vascular-specific CXCR4 repressor and exploited a target-site blocker (CXCR4-TSB) that disrupted the interaction of miR-206-3p with CXCR4 in vitro and in vivo. In vitro, CXCR4-TSB enhanced CXCR4 expression in human and murine ECs and VSMCs to modulate cell viability, proliferation, and migration. Systemic administration of CXCR4-TSB in Apoe -deficient mice enhanced Cxcr4 expression in ECs and VSMCs in the walls of blood vessels, reduced vascular permeability and monocyte adhesion to endothelium, and attenuated the development of diet-induced atherosclerosis. CXCR4-TSB also increased CXCR4 expression in B cells, corroborating its atheroprotective role in this cell type. Analyses of human atherosclerotic plaque specimens revealed a decrease in CXCR4 and an increase in miR-206-3p expression in advanced compared with early lesions, supporting a role for the miR-206-3p–CXCR4 interaction in human disease. Disrupting the miR-206-3p–CXCR4 interaction in a cell-specific manner with target-site blockers is a potential therapeutic approach that could be used to treat atherosclerosis and other vascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsAtherosclerosisPlaque, AtheroscleroticHumansAnimalsMiceEndothelial CellsReceptors, CXCR4Cell ProliferationMyocytes, Smooth MuscleCell Movement

Substanzen

MicroRNAsReceptors, CXCR4CXCR4 protein, humanMIRN206 microRNA, human

Autor:innen und Institutionen

  • Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-Universität München, 80336 Munich, Germany.
  • German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, 80336 Munich, Germany.
  • Anthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians-Universität München, 85152 Planegg-Martinsried, Germany.
  • Department of Biomedical Engineering, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, 6200 MD Maastricht, Netherlands.
  • Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, 52074 Aachen, Germany.
  • Interdisciplinary Center for Clinical Research (IZKF), RWTH Aachen University, 52062 Aachen, Germany.

ORCID-Profile: Ismail Cimen, Lucia Natarelli, James M Henderson, Floriana M Farina, Eva Briem, Maria Aslani, Remco T A Megens, Johan Duchêne, Andreas Schober, Donato Santovito, Christian Weber

Zitieren

APA

Cimen, I., Natarelli, L., Abedi Kichi, Z., Henderson, J. M., Farina, F. M., Briem, E., Aslani, M., Megens, R. T. A., Jansen, Y., Mann-Fallenbuchel, E., Gencer, S., Duchêne, J., Nazari-Jahantigh, M., van der Vorst, E. P. C., Enard, W., Döring, Y., Schober, A., Santovito, D., & Weber, C. (2023). Targeting a cell-specific microRNA repressor of CXCR4 ameliorates atherosclerosis in mice. Science Translational Medicine, 15(720). https://doi.org/10.1126/scitranslmed.adf3357

Vancouver

Cimen I, Natarelli L, Abedi Kichi Z, Henderson JM, Farina FM, Briem E, et al. Targeting a cell-specific microRNA repressor of CXCR4 ameliorates atherosclerosis in mice. Science Translational Medicine. 2023;15(720). doi:10.1126/scitranslmed.adf3357

BibTeX
@article{Cimen2023,
  author = {Cimen, Ismail and Natarelli, Lucia and Abedi Kichi, Zahra and Henderson, James M and Farina, Floriana M and Briem, Eva and Aslani, Maria and Megens, Remco T A and Jansen, Yvonne and Mann-Fallenbuchel, Elizabeth and Gencer, Selin and Duchêne, Johan and Nazari-Jahantigh, Maliheh and van der Vorst, Emiel P C and Enard, Wolfgang and Döring, Yvonne and Schober, Andreas and Santovito, Donato and Weber, Christian},
  title = {Targeting a cell-specific microRNA repressor of CXCR4 ameliorates atherosclerosis in mice},
  journal = {Science Translational Medicine},
  year = {2023},
  volume = {15},
  number = {720},
  doi = {10.1126/scitranslmed.adf3357}
}
Kostenlos starten →